Oncopeptides AB (publ) 0RN4.IL Stock
Oncopeptides AB (publ) Price Chart
Oncopeptides AB (publ) 0RN4.IL Financial and Trading Overview
| Oncopeptides AB (publ) stock price | 4.96 SEK |
| Previous Close | 8.22 SEK |
| Open | 0 SEK |
| Bid | 7.93 SEK x N/A |
| Ask | 8.61 SEK x N/A |
| Day's Range | 8.19 - 8.19 SEK |
| 52 Week Range | 7.79 - 50.44 SEK |
| Volume | 11.2K SEK |
| Avg. Volume | 4.48K SEK |
| Market Cap | 741.05M SEK |
| Beta (5Y Monthly) | -0.605747 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.39 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0RN4.IL Valuation Measures
| Enterprise Value | 529.43M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 78.178566 |
| Price/Book (mrq) | 3.3817217 |
| Enterprise Value/Revenue | 55.853 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Oncopeptides AB (publ) Stock Price History
| Beta (5Y Monthly) | -0.605747 |
| 52-Week Change | -24.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 50.44 SEK |
| 52 Week Low | 7.79 SEK |
| 50-Day Moving Average | 9.41 SEK |
| 200-Day Moving Average | 12.82 SEK |
0RN4.IL Share Statistics
| Avg. Volume (3 month) | 4.48K SEK |
| Avg. Daily Volume (10-Days) | 12.65K SEK |
| Shares Outstanding | 90.37M |
| Float | 59.28M |
| Short Ratio | N/A |
| % Held by Insiders | 10.01% |
| % Held by Institutions | 46.49% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3409.90% |
| Gross Margin | 99.82% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.90% |
| Return on Equity (ttm) | -178.61% |
Income Statement
| Revenue (ttm) | 9.48M SEK |
| Revenue Per Share (ttm) | 0.11 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 8.35M SEK |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -310388992 SEK |
| Diluted EPS (ttm) | -3.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 251.9M SEK |
| Total Cash Per Share (mrq) | 2.67 SEK |
| Total Debt (mrq) | 4.41M SEK |
| Total Debt/Equity (mrq) | 1.93 SEK |
| Current Ratio (mrq) | 3.532 |
| Book Value Per Share (mrq) | 2.422 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -343472992 SEK |
| Levered Free Cash Flow (ttm) | -230872496 SEK |
Profile of Oncopeptides AB (publ)
| Country | United Kingdom |
| State | N/A |
| City | Stockholm |
| Address | Vastra Tradgardsgatan 15 |
| ZIP | 111 53 |
| Phone | 46 86 15 20 40 |
| Website | https://www.oncopeptides.com/sv |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 59 |
Oncopeptides AB (publ), a biotech company, engages in the commercialization, and research and development of treatments for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is melflufen, a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden
Q&A For Oncopeptides AB (publ) Stock
What is a current 0RN4.IL stock price?
Oncopeptides AB (publ) 0RN4.IL stock price today per share is 4.96 SEK.
How to purchase Oncopeptides AB (publ) stock?
You can buy 0RN4.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncopeptides AB (publ)?
The stock symbol or ticker of Oncopeptides AB (publ) is 0RN4.IL.
Which industry does the Oncopeptides AB (publ) company belong to?
The Oncopeptides AB (publ) industry is Biotechnology.
How many shares does Oncopeptides AB (publ) have in circulation?
The max supply of Oncopeptides AB (publ) shares is 102.56M.
What is Oncopeptides AB (publ) Price to Earnings Ratio (PE Ratio)?
Oncopeptides AB (publ) PE Ratio is now.
What was Oncopeptides AB (publ) earnings per share over the trailing 12 months (TTM)?
Oncopeptides AB (publ) EPS is -3.39 SEK over the trailing 12 months.
Which sector does the Oncopeptides AB (publ) company belong to?
The Oncopeptides AB (publ) sector is Healthcare.